OpSens: Haemonetics to acquire medical device cardiology company OpSens

Per the terms of the agreement Haemonetics will acquire all of OpSens' issued and outstanding common shares in the capital. Haemonetics will acquire all outstanding shares of OpSens for CAD $2.90 per share in cash. The transaction is valued at approximately $253 million at the current exchange rate on a fully diluted equity basis. ...